These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34505827)

  • 21. Hepatitis A and B vaccination in adults at risk: A survey of US healthcare providers' attitudes and practices.
    Herrera-Restrepo O; Davis K; Sweeney C; Davenport E; Ghaswalla P; Buck PO
    Hum Vaccin Immunother; 2022 Nov; 18(6):2123180. PubMed ID: 36287135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations.
    Rosenthal EM; Hall EW; Rosenberg ES; Harris A; Nelson NP; Schillie S
    Vaccine; 2020 Dec; 38(51):8206-8215. PubMed ID: 33160756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
    Bruxvoort K; Slezak J; Qian L; Sy LS; Ackerson B; Reynolds K; Huang R; Solano Z; Towner W; Mercado C; Jacobsen SJ
    JAMA; 2022 Apr; 327(13):1260-1268. PubMed ID: 35333303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant.
    Schillie S; Harris A; Link-Gelles R; Romero J; Ward J; Nelson N
    MMWR Morb Mortal Wkly Rep; 2018 Apr; 67(15):455-458. PubMed ID: 29672472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Hepatitis B Vaccination with a Novel Immunostimulatory Sequence Adjuvant (Heplisav-B) in Patients With Inflammatory Bowel Disease.
    Kwon JY; Daoud ND; Hashash JG; Picco MF; Farraye FA
    Inflamm Bowel Dis; 2023 Feb; 29(2):254-259. PubMed ID: 35468183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience.
    van den Ende C; Marano C; van Ahee A; Bunge EM; De Moerlooze L
    Expert Rev Vaccines; 2017 Aug; 16(8):789-809. PubMed ID: 28586278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60-70 years.
    Hyer RN; Janssen RS
    Vaccine; 2019 Sep; 37(39):5854-5861. PubMed ID: 31431412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges with hepatitis B vaccination of high risk adults - A pilot program.
    Bridges CB; Watson TL; Nelson NP; Chavez-Torres M; Fineis P; Ntiri-Reid B; Wake E; Leahy JM; Kurian AK; Hall MAK; Kennedy ED
    Vaccine; 2019 Aug; 37(35):5111-5120. PubMed ID: 31303523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perinatal hepatitis B prevention program in Shandong Province, China. Evaluation and progress.
    Zhang L; Ko S; Lv J; Ji F; Yan B; Xu F; Xu A
    Hum Vaccin Immunother; 2014; 10(9):2755-60. PubMed ID: 25483482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of newborn hepatitis B vaccination--worldwide, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1249-52. PubMed ID: 19023261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses.
    Qiu J; Zhang S; Feng Y; Su X; Cai J; Chen S; Liu J; Huang S; Huang H; Zhu S; Wen H; Li J; Yan H; Diao Z; Liang X; Zeng F
    Expert Rev Vaccines; 2024; 23(1):69-81. PubMed ID: 38055218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) Update.
    Lee GH; Lim SG
    Expert Rev Vaccines; 2021 May; 20(5):487-495. PubMed ID: 33783302
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antibody persistence following booster vaccination with three doses of hepatitis B vaccines among low-response adults in Zhangqiu county of Shandong province: 24-month of follow-up from 2009].
    Yan B; Lyu J; Liu J; Feng Y; Xu A; Chen S; Zhou L; Liang X; Cui F; Wang F; Zhang L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Dec; 48(12):1043-7. PubMed ID: 25619213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.
    Cooper CL; Davis HL; Angel JB; Morris ML; Elfer SM; Seguin I; Krieg AM; Cameron DW
    AIDS; 2005 Sep; 19(14):1473-9. PubMed ID: 16135900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course.
    Nicolini LA; Magne F; Signori A; Di Biagio A; Sticchi L; Paganino C; Durando P; Viscoli C
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):922-928. PubMed ID: 29926738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of a 3-antigen versus single-antigen vaccine for the prevention of hepatitis B in adults in the United States.
    Talbird SE; Anderson SA; Nossov M; Beattie N; Rak AT; Diaz-Mitoma F
    Vaccine; 2023 May; 41(23):3506-3517. PubMed ID: 37147201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal knowledge and infant uptake of valid hepatitis B vaccine birth dose at routine immunization clinics in Enugu State - Nigeria.
    Okenwa UJ; Dairo MD; Bamgboye E; Ajumobi O
    Vaccine; 2020 Mar; 38(12):2734-2740. PubMed ID: 32007294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China.
    Yu W; Liu D; Zheng J; Liu Y; An Z; Rodewald L; Zhang G; Su Q; Li K; Xu D; Wang F; Yuan P; Xia W; Ning G; Zheng H; Chu Y; Cui J; Duan M; Hao L; Zhou Y; Wu Z; Zhang X; Cui F; Li L; Wang H
    Int J Epidemiol; 2016 Apr; 45(2):441-9. PubMed ID: 27174834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of HepB-CpG in women with documented pregnancies post-vaccination: A retrospective chart review.
    Kushner T; Huang V; Janssen R
    Vaccine; 2022 May; 40(21):2899-2903. PubMed ID: 35430105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of rapid hepatitis B vaccination with different vaccine dosages and types in adults].
    Nie L; Pang XH; Zhang Z; Ma JX; Liu XY; Qiu Q; Liang Y; Li Q; Zhang W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1151-1155. PubMed ID: 28910921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.